Rationale for Considering Oral Idasanutlin as a Therapeutic Option for COVID-19 Patients

Detalles Bibliográficos
Autores principales: Zauli, Giorgio, Tisato, Veronica, Secchiero, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403220/
https://www.ncbi.nlm.nih.gov/pubmed/32848765
http://dx.doi.org/10.3389/fphar.2020.01156

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7403220/
https://www.ncbi.nlm.nih.gov/pubmed/32848765
http://dx.doi.org/10.3389/fphar.2020.01156

Ejemplares similares